VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
MinerviniVCP SetupsTrend Template
O'NeilCup with HandleFlat BaseDouble BottomCANSLIM Leaders
QullamaggieHigh Tight FlagsFlag BreakoutsEpisodic PivotsMomentum Leaders
KellWedge PopEMA Crossback
LivermorePivotal Points
PatternsFalling Wedge & ChannelBase Breakouts
View All Playbooks...
BreakoutsScanner
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
BreakoutsScanner
WatchlistPricing
Ctrl K
Pricing
BRKR
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Scanner
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsScannerWatchlist
BRKRBruker Corporation
$61.31$9.3B
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
HomeStocksBRKRFinancials

Bruker Corporation (BRKR) Income Statement

27Y historyFree accessUpdated daily

Revenue reached $874.0M in Q3 2026 but year-over-year growth has compressed to about 1.6%, while operating margin deteriorated to -10.4% and net margin to -12.8%, suggesting that fixed SG&A costs are absorbing gross profit gains.

Income StatementBalance SheetCash FlowRatios

BRKR Income Statement

Annual statement

BRKR Income Statement

Bruker Corporation (BRKR) annual income statement — 27-year revenue, gross profit & net income history

AnnualQuarterly
MetricTTMDec'25Dec'24Dec'23Dec'22Dec'21Dec'20Dec'19Dec'18Dec'17Dec'16Dec'15Dec'14Dec'13Dec'12Dec'11Dec'10Dec'09Dec'08Dec'07Dec'06Dec'05Dec'04Dec'03Dec'02Dec'01Dec'00Dec'99
Sales/Revenue3.51B3.44B3.37B2.96B2.53B2.42B1.99B2.07B1.9B1.77B1.61B1.62B1.81B1.84B1.79B1.65B1.3B1.11B1.11B547.58M435.83M297.57M284.42M260.68M116.37M92.69M76.6M64.69M
Revenue Growth %2.16%2.08%13.56%17.14%4.67%21.66%-4.11%9.34%7.34%9.59%-0.77%-10.23%-1.66%2.68%8.46%26.58%17.08%0.67%102.18%25.64%46.46%4.62%9.11%124.01%25.54%21%18.41%-
Cost of Goods Sold1.83B1.86B1.72B1.45B1.23B1.21B1.05B1.08B995.6M952.9M868.8M915.2M1.05B1.03B960M899.2M698.9M595.9M602.1M294.44M236.5M171.76M165.94M144.83M55.87M43.59M35.59M28.13M
COGS % of Revenue-54.09%51%48.95%48.41%49.97%52.71%51.98%52.52%53.96%53.92%56.36%57.8%56.22%53.59%54.44%53.56%53.47%54.39%53.77%54.26%57.72%58.34%55.56%48.01%47.03%46.46%43.49%
Gross Profit1.68B1.58B1.65B1.51B1.31B1.21B939.8M995.3M900M813M742.5M708.6M763.3M805.2M831.4M752.5M606M518.6M505M253.14M199.33M125.81M118.48M115.84M60.5M49.1M41.02M36.56M
Gross Margin %47.93%45.91%49%51.05%51.59%50.03%47.29%48.02%47.48%46.04%46.08%43.64%42.2%43.78%46.41%45.56%46.44%46.53%45.61%46.23%45.74%42.28%41.66%44.44%51.99%52.97%53.54%56.51%
Gross Profit Growth %--4.35%9%15.9%7.94%28.71%-5.58%10.59%10.7%9.49%4.78%-7.17%-5.2%-3.15%10.48%24.17%16.85%2.69%99.5%26.99%58.44%6.19%2.27%91.49%23.2%19.72%12.19%-
Operating Expenses1.68B1.34B1.4B1.08B873M796.3M691.5M694.4M618.1M578.6M539.5M537.9M625.2M628.4M637.7M596.9M450.3M255.3M388.3M198.51M162.95M115.17M119.59M125.53M54.75M45.83M40.28M33.38M
OpEx % of Revenue-39.04%41.48%36.31%34.5%32.93%34.79%33.5%32.61%32.77%33.48%33.13%34.56%34.16%35.6%36.14%34.51%22.91%35.07%36.25%37.39%38.7%42.05%48.15%47.05%49.44%52.58%51.6%
Selling, General & Admin954.7M946.5M893.8M729.4M607.4M562.3M477.8M504.8M444.7M415.9M390.5M392.2M451M437.9M442.4M403.6M297.3M255.3M254.5M140.04M112.99M73.81M76.38M77.75M33.81M27.72M20.25M14.76M
SG&A % of Revenue-27.54%26.55%24.6%24%23.26%24.04%24.36%23.46%23.55%24.24%24.15%24.93%23.81%24.7%24.44%22.78%22.91%22.99%25.57%25.92%24.8%26.85%29.83%29.06%29.9%26.43%22.81%
Research & Development387.2M395.2M376.5M294.8M235.9M220.8M198M187.7M173.4M162.7M149M145.7M174.2M190.5M195.3M177.2M141.4M126.4M133.8M58.47M49.96M41.36M43.22M38.03M20.73M18.47M20.03M15.14M
R&D % of Revenue-11.5%11.18%9.94%9.32%9.13%9.96%9.06%9.15%9.21%9.25%8.97%9.63%10.36%10.9%10.73%10.84%11.34%12.09%10.68%11.46%13.9%15.2%14.59%17.82%19.92%26.15%23.4%
Other Operating Expenses1.9M0126.1M52.2M29.7M13.2M15.7M1.9M000000013.1M5.8M200K000009.74M202K-356K03.49M
Operating Income500K236M253.1M436.9M432.7M413.3M248.3M300.9M262.4M214.7M177.2M145.7M105.4M148.2M156M155.6M155.7M136.7M108.2M49.97M30.66M10.64M-1.12M-9.68M5.75M3.27M734K3.18M
Operating Margin %0.01%6.87%7.52%14.74%17.1%17.09%12.49%14.52%13.84%12.16%11%8.97%5.83%8.06%8.71%9.42%11.93%12.27%9.77%9.13%7.04%3.57%-0.39%-3.71%4.94%3.53%0.96%4.91%
Operating Income Growth %--6.76%-42.07%0.97%4.69%66.45%-17.48%14.67%22.22%21.16%21.62%38.24%-28.88%-5%0.26%-0.06%13.9%26.34%116.54%62.96%188.23%1051.52%88.45%-268.51%75.53%345.91%-76.91%-
EBITDA145.6M456.3M436.9M551.8M521.4M502.4M328.8M376.5M327.3M278.6M231.5M199M165.1M209.5M215.1M158.6M161.5M166.4M138.1M62.59M43.95M19.25M8.68M7.19M13.94M9.31M4.88M6.66M
EBITDA Margin %4.14%13.28%12.98%18.61%20.6%20.78%16.54%18.17%17.27%15.78%14.37%12.26%9.13%11.39%12.01%9.6%12.38%14.93%12.47%11.43%10.08%6.47%3.05%2.76%11.98%10.05%6.37%10.3%
EBITDA Growth %-60.21%4.44%-20.82%5.83%3.78%52.8%-12.67%15.03%17.48%20.35%16.33%20.53%-21.19%-2.6%35.62%-1.8%-2.94%20.49%120.62%42.42%128.36%121.86%20.62%-48.41%49.68%90.88%-26.79%-
D&A (Non-Cash Add-back)174.4M220.3M183.8M114.9M88.7M89.1M80.5M75.6M64.9M63.9M54.3M53.3M59.7M61.3M59.1M3M5.8M29.7M29.9M12.63M13.29M8.61M9.79M16.87M8.2M6.04M4.14M3.49M
EBIT-51.2M82.3M254.8M560.6M430M407.9M240.2M296.4M275.2M235.6M207.8M182.6M114.6M177.8M152.6M152.8M155.7M136.6M104.9M50.45M36.39M22.42M-2.74M-9.68M5.65M1.37M734K3.18M
Net Interest Income-18.5M-45.5M-38.6M-8.9M-13.3M-13.4M-11.2M-14.7M-11.4M-14.6M-12.9M-11.8M-5.2M-12.4M-13.4M-5.7M-4.1M-6.5M-6.8M000000000
Interest Income4.9M14.8M9.3M7.5M2.8M900K3.2M1.3M1.2M800K300K1.2M800K1M900K1M900K1M4.9M000000000
Interest Expense23.4M60.3M47.9M16.4M16.1M14.3M14.4M16M12.6M15.4M13.2M13M6M13.4M14.3M7.3M5.6M7.5M40.5M11.84M3.96M03.85M6.36M20.15M001.35M
Other Income/Expense-76.3M-215M-47.9M109.3M-17.8M-19.7M-22.5M-20.5M-17.7M-21.7M-4.2M-17.7M-4.1M-23.6M-17.7M-10.1M-5.6M-7.6M-15M-89.09M3.76M-780K-3.78M1.85M-9.88M2.73M1.59M-1.32M
Pretax Income-75.8M21M205.2M546.2M414.9M393.6M225.8M280.4M244.7M197.8M177.6M128M101.3M124.6M138.3M145.5M150.1M129.1M93.2M48.61M34.42M11.95M-4.9M-7.83M-4.14M6.01M2.32M1.86M
Pretax Margin %-2.16%0.61%6.1%18.42%16.39%16.28%11.36%13.53%12.91%11.2%11.02%7.88%5.6%6.77%7.72%8.81%11.5%11.58%8.42%8.88%7.9%4.02%-1.72%-3%-3.56%6.48%3.03%2.88%
Income Tax42.3M29.3M91.4M117.7M116.4M113M64.4M82.4M63.7M117.5M23.1M23.1M41.7M42.8M60.1M51.5M53.3M48.1M28M16.78M15.93M8.26M2.87M9.72M2.06M2.37M254K986.89K
Effective Tax Rate %-55.8%139.52%44.54%21.55%28.05%28.71%28.52%29.39%26.03%59.4%13.01%18.05%41.16%34.35%43.46%35.4%35.51%37.26%30.04%34.53%46.28%69.15%-58.51%-124.19%-49.87%39.44%10.95%52.98%
Net Income-123.4M-8.6M113.1M427.2M296.6M277.1M157.8M197.2M179.7M78.6M153.6M101.6M56.7M80.1M77.5M92.3M95.4M81.2M64.9M31.53M18.48M3.65M-7.83M-17.55M-6.2M3.64M2.25M1.25M
Net Margin %-3.51%-0.25%3.36%14.41%11.72%11.46%7.94%9.51%9.48%4.45%9.53%6.26%3.13%4.35%4.33%5.59%7.31%7.29%5.86%5.76%4.24%1.23%-2.75%-6.73%-5.33%3.92%2.94%1.93%
Net Income Growth %-490.43%-107.6%-73.53%44.03%7.04%75.6%-19.98%9.74%128.63%-48.83%51.18%79.19%-29.21%3.35%-16.03%-3.25%17.49%25.12%105.84%70.6%406.88%146.56%55.39%-183.13%-270.47%61.64%80.07%-
Net Income (Continuing)-118.1M-8.3M113.8M428.5M298.5M280.6M161.4M198M181M80.3M154.5M104.9M59.6M81.8M78.2M94M96.8M81M65.2M31.83M18.49M9.79M-7.76M-17.55M-6.18M2.69M2.07M876.04K
Discontinued Operations0000000000000000000000000000
Minority Interest37M53.8M34M36.1M18M14.3M13.1M31.4M8.5M8.1M6.7M6.8M5.8M4.1M3.1M3.4M2.7M1.6M800K538K239K233K193K124K0000
EPS (Diluted)-0.81-0.150.762.901.991.811.021.261.140.490.950.600.330.480.460.550.580.490.390.600.180.10-0.08-0.17-0.12-0.050.040.03
EPS Growth %-586.94%-119.74%-73.79%45.73%9.94%77.45%-19.05%10.53%132.65%-48.42%58.33%81.82%-31.25%4.35%-16.36%-5.17%18.37%25.64%-35%233.33%86.72%218.57%52.18%-41.67%-140%-225%33.33%-
EPS (Basic)--0.150.762.922.001.831.031.271.150.500.950.600.340.480.470.560.580.500.400.610.180.10-0.08-0.17-0.12-0.050.040.03
Diluted Shares Outstanding152.5M151.8M149.5M147.2M149.4M152.9M154.6M156.6M157.2M159.1M162.2M169.1M169.5M168.5M167.4M166.9M165.7M164.9M165.6M164.3M102.56M101.13M96.38M103.26M52.6M54.06M56.25M45.5M
Basic Shares Outstanding152.5M151.8M149M146.4M148.6M151.4M153.4M155.2M156.2M158.1M161.4M168.2M167.8M166.5M166M165.4M164.4M163.5M162.7M161.2M101.51M100.82M96.38M103.26M52.6M54.06M56.25M45.5M
Dividend Payout Ratio--26.7%6.88%10.05%8.73%15.59%12.68%13.97%32.32%16.8%-----0.1%-594.76%---------

Key Metrics

Growth RegimeStable
ProfitabilityStrained
Balance SheetAdequate
Cash FlowStable
Top Statement Risk

Negative net margin persistence

Verified Source

Metrics are mathematically derived from official filings.

SEC 10-K (2026Q3)

Top-Line Growth Has Flattened Materially

Based on reported quarterly figures, Bruker's revenue rose from $800.7M in Q2 2024 to $874.0M in Q3 2026, but year-over-year growth has compressed to roughly 1.6% to 2.1% in the latest periods, well below the mid-teens pace seen through 2024.

The deceleration from double-digit growth in 2024 to low single digits in 2026 suggests demand from core academic and government buyers has slowed or that prior acquisitions have lapped. Because the data does not isolate organic from acquired revenue, investors should monitor whether reported growth is sustaining instruments demand or merely reflecting portfolio additions. Durability of growth above 5% appears uncertain on current evidence.

Gross Margin Holds Above Peer Pressure

As reported in the income statement, Bruker's gross margin of roughly 47% to 50% through 2026 sits below Waters at 57.8% and Trimble at 68.3%, though it has recovered from a 44% trough in Q3 2025.

The recovery in gross margin in the first half of 2026 suggests some improvement in product mix or cost absorption, but the persistent gap to specialty tools peers points to a structurally lower pricing position. The margin profile appears sensitive to the lower-margin BEST and NANO segments, so mix shifts could move results materially in either direction.

Operating Leverage Has Reversed Sharply

Based on reported figures, operating margin swung from a positive 7.9% in Q3 2024 to negative 10.4% in Q3 2026, with SG&A remaining near $226M to $247M per quarter while gross profit fell.

The fixed-cost base of SG&A and R&D appears not to have scaled down with the revenue plateau, which indicates negative operating leverage in recent quarters. This suggests that even modest top-line softness can erase operating profit, warranting close attention to cost discipline and restructuring progress.

Net Losses Outpace Operating Trends

According to reported quarterly results, Bruker posted net losses of $111.8M in Q3 2026 and $52.0M in Q2 2026, with EPS of -0.81 and -0.41, a gap wider than operating losses alone would imply.

The divergence between operating loss and net loss suggests material non-operating charges, interest expense, or integration-related items, though the supplied data does not decompose these. Investors should treat the reported net figures as warranting further investigation rather than as a settled measure of underlying earnings power.

Bear Case Rests on Sustained Losses

Based on reported figures, a Debt/Equity ratio of 0.81 combined with negative net margins and return on equity near -0.4% leaves limited room for further operating deterioration before balance-sheet flexibility is constrained.

The bear argument centers on whether recent acquisitions and integration costs are structural rather than temporary, which would imply a lower earnings base for the foreseeable future. If operating margins do not recover toward the 11% seen in Q4 2025, the current leverage level may increase sensitivity to interest rates and refinancing conditions. The latest earnings event lacks a confirmed EPS result and guidance tone, so this assessment should be revisited once reconciled results are available.

BRKR — Frequently Asked Questions

Quick answers to the most common questions about buying BRKR stock.

What was Bruker Corporation's (BRKR) revenue in 2025?

For fiscal year 2025, Bruker Corporation (BRKR) reported total revenue of $3.44B. This represents a 5212.2% increase compared to $64.7M in 1999.

Is Bruker Corporation (BRKR) profitable?

Bruker Corporation (BRKR) reported a net loss of $8.6M for the fiscal year ending 2025.

What is Bruker Corporation's operating profit margin?

Bruker Corporation (BRKR) reported an operating income of $236.0M, resulting in an operating profit margin of 6.9%. This margin reflects the operational efficiency of the business before interest and taxes.

What is Bruker Corporation's gross profit and gross margin?

Bruker Corporation (BRKR) generated $1.58B in gross profit for the year, representing a gross profit margin of 45.9%. This demonstrates the company's core pricing power and production efficiency.